Concerto HealthAI on Monday, Jan. 13, announced the launch of its new real-world evidence platform, eurekaHealth 3.0, which combines real-world data and artificial intelligence to deliver “high-performance” RWE.
According to a press release, the eurekaHealth 3.0 merges the ” largest and most comprehensive array of research-ready RWD with advanced AI capabilities for ‘on-demand’ precision analyses and patient insights.”
“This is the first precision oncology system that integrates advanced, scalable, production-ready data science and Concerto HealthAI’s superior RWD for high-performance RWE – to become an integral part of the enterprise operating model,” Concerto HealthAI CEO Jeff Elton said in a statement. “Researchers no longer have to make compromises when it comes to precision and productivity.”
To read the full press release, click here.